-
Sandoz Expands Antibiotics Production with New Austrian Factory
•
Sandoz (OTCMKTS: SDZNY), a Swiss pharmaceutical company, has announced the opening of a new antibiotics manufacturing site in Austria, marking a significant expansion in its production capabilities. The annual production capacity in the city has increased from 200 million to 240 million packages, following the completion of a 3,000 square…
-
BeiGene Launches Legal Action Against Sandoz and MSN Over Brukinsa Patent Infringement
•
BeiGene Ltd. (NASDAQ: BGNE; HKG: 6160; SHA: 688235), the China-based biotech firm, has initiated patent infringement proceedings against two generics manufacturers: Switzerland’s Sandoz Inc. (OTCMKTS: SDZNY) and U.S.-based MSN Pharmaceuticals. This legal action follows notifications received from both companies regarding their Abbreviated New Drug Applications (ANDAs) submitted to the U.S.…
